Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christoph Irlbeck
Observed names:
C. Irlbeck,
Irlbeck, Christoph
Institutions:
University Hospital Regensburg,
Fraunhofer Institute for Toxicology and Experimental Medicine
Observed institutions:
University Hospital Regensburg,
Fraunhofer Institute for Toxicology and Experimental Medicine,
Fraunhofer-Gesellschaft,
University of Regensburg
ORCID:
0000-0002-0097-5639
Observed ORCID:
0000-0002-0097-5639
OpenAlex ID:
A5010827664
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency
2020
·
Melanie Werner-Klein
, Ana Grujovic
, et al.
·
Nature Communications
·
62
PDF
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
2021
·
Anja Kathrin Wege
, Eva‐Maria Rom‐Jurek
, et al.
·
International Journal of Cancer
·
15
PDF
The Drosophila functional Smad suppressing element fuss, a homologue of the human Skor genes, retains pro-oncogenic properties of the Ski/Sno family
2022
·
Mathias Rass
, Laura Gizler
, et al.
·
PLoS ONE
·
4
PDF
Molecular characterization of disseminated cancer cells isolated from patients with luminal B type breast cancer
2021
·
Irlbeck, Christoph
·
University of Regensburg Publication Server (University of Regensburg)
·
1
Abstract LB-312: Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
2019
·
Melanie Werner-Klein
, Ana Grujovic
, et al.
·
Cancer Research
·
1
Metastatic founder cell candidates resemble preimplantation embryonic blastomeres
2026
·
Huiqin Körkel-Qu
, Elia Raya
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 3788: EpCAM+ DCCs isolated from the bone marrow of breast cancer patients display high stemness and potency scores
2024
·
Elia Raya
, Huiqin Koerkel-Qu
, et al.
·
Cancer Research
Eine mdm2 Genamplifikation ist mit Progression und Metastasierung des luminalen Mammakarzinoms im humanisierten Tumormausmodell (hPDX) assoziiert, sowie mit einem ungünstigen klinischen Verlauf der Erkrankung
2022
·
G. Brockhoff
, E.-M.Rom Jurek
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Abstract PD9-07: Mdm2 gene amplification in estrogen receptor-positive breast cancer cells is associated with enhanced solid tumor growth and pronounced metastatic potential in humanized tumor mice (HTM) and a poor outcome of patients with luminal breast cancer
2022
·
Anja Kathrin Wege
, Valentina Vladimirova
, et al.
·
Cancer Research
Abstract LB-312: Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
2019
·
Melanie Werner-Klein
, Ana Grujovic
, et al.
·
Tumor Biology
Show more works
View as search
Works count:
10
Citation count:
83
H-index:
3
I10-index:
2
Year
Topic
Type